Literature DB >> 16258952

Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation.

Ian Gooding1, Vicky Dondos, Khin Ma Gyi, Margaret Hodson, David Westaby.   

Abstract

Autopsy and imaging studies show that liver involvement is common in cystic fibrosis. However, complications of chronic liver disease including portal hypertension and variceal bleeding are infrequently encountered, and the degree to which variceal hemorrhage affects prognosis in cystic fibrosis is unclear. This uncertainty has lead to debate as to whether liver transplantation is indicated in these patients. We describe a case series of 18 patients and compare their survival with a control group of cystic fibrosis patients without liver disease. The median age at first bleed was 20.0 years (range 9.7-30.9). The median survival after first bleed was 8.4 years, compared to 13.0 years in the control group (P = 0.15). A total of 14 patients have died, 9 from respiratory disease with no discernable contribution from their liver disease. Liver disease contributed to 4 deaths. Only 1 patient suffered a fatal hemorrhage, which may have been either variceal or bronchial in origin. Long-term survival is a frequent occurrence in patients with cystic fibrosis who suffer variceal hemorrhage, and age at death is comparable to the general cystic fibrosis population. In conclusion, this suggests that liver transplantation is not indicated in these patients without additional features of liver decompensation.

Entities:  

Mesh:

Year:  2005        PMID: 16258952     DOI: 10.1002/lt.20465

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  11 in total

Review 1.  Hepatic Manifestations of Cystic Fibrosis.

Authors:  Sasan Sakiani; David E Kleiner; Theo Heller; Christopher Koh
Journal:  Clin Liver Dis       Date:  2019-02-21       Impact factor: 6.126

Review 2.  Cystic fibrosis liver disease: A condition in need of structured transition and continuity of care.

Authors:  Julian Hercun; Fernando Alvarez; Catherine Vincent; Marc Bilodeau
Journal:  Can Liver J       Date:  2019-08-27

3.  Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis.

Authors:  Wen Ye; Michael R Narkewicz; Daniel H Leung; Wikrom Karnsakul; Karen F Murray; Estella M Alonso; John C Magee; Sarah Jane Schwarzenberg; Alexander Weymann; Jean P Molleston
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

Review 4.  Interventions for preventing and managing advanced liver disease in cystic fibrosis.

Authors:  Senthil K Palaniappan; Nan Nitra Than; Aung Win Thein; Soe Moe; Indra van Mourik
Journal:  Cochrane Database Syst Rev       Date:  2017-08-29

Review 5.  Cystic fibrosis from the gastroenterologist's perspective.

Authors:  Chee Y Ooi; Peter R Durie
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-21       Impact factor: 46.802

Review 6.  Idiopathic noncirrhotic portal hypertension: current perspectives.

Authors:  Oliviero Riggio; Stefania Gioia; Ilaria Pentassuglio; Valeria Nicoletti; Michele Valente; Giulia d'Amati
Journal:  Hepat Med       Date:  2016-07-27

7.  Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.

Authors:  Pierre-Yves Boëlle; Dominique Debray; Loic Guillot; Annick Clement; Harriet Corvol
Journal:  Hepatology       Date:  2018-12-28       Impact factor: 17.425

Review 8.  Cystic Fibrosis Liver Disease: Know More.

Authors:  Siham Al Sinani; Sharef Al-Mulaabed; Khalid Al Naamani; Rabab Sultan
Journal:  Oman Med J       Date:  2019-11

Review 9.  Cystic fibrosis associated liver disease in children.

Authors:  Joseph J Valamparampil; Girish L Gupte
Journal:  World J Hepatol       Date:  2021-11-27

10.  Etiology and management of hemorrhagic complications of portal hypertension in children.

Authors:  Alejandro Costaguta; Fernando Alvarez
Journal:  Int J Hepatol       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.